Category: Pharmaceuticals
Spain Pharmaceuticals
-
Global & Spain Cancer Therapeutics Market to 2031
... demand for effective cancer therapies and improved patient care. The Spanish government actively promotes cancer awareness, supports innovation, and works to enhance access to advanced, life-saving treatments. On May 6, 2024, the European Cancer Organisation ... Read More
-
Spain Biosimilars Market Overview, 2030
... pharmaceutical industry in Spain, offering a more affordable and accessible alternative to biological drugs. Currently, there are a number of biosimilars available in Spain, including versions of drugs used to treat cancer, autoimmune diseases, and ... Read More
-
Pharmaceutical Product & Preparations Manufacturing in Spain - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
Spain Diabetes Devices and Therapeutics Market Investment Opportunities – Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape – Q2 2025 Update
... a CAGR of 10.1%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 7.8% during 2025-2029. By the end of 2029, the diabetes market is projected to ... Read More
-
Rx/Reimbursement Adult Incontinence in Spain
... only a commitment to improving patient care but also a recognition of the significant growth potential. The system provides financial support for a range of essential supplies such as super absorbent briefs, all-in-one diapers, pull-up... ... Read More
-
Global Medical Tourism Market Size Study, By Treatment Type (Cardiovascular Treatment, Orthopedic Treatment, Cosmetic Treatment, Bariatric Treatment, Dental Treatment, Ophthalmology Treatment, Infertility Treatment, Alternative Medicine, Other Services), By Service Provider (Public, Private), By Country (Thailand, India, Mexico, Malaysia, Singapore, Brazil, Colombia, Turkey, Taiwan, South Korea, Spain, Czech Republic, China, Australia, Indonesia), and Regional Forecasts 2022-2032
... healthcare costs in developed nations, leading patients to seek affordable, high-quality medical treatments abroad. Medical tourism offers significant cost savings, particularly for elective procedures such as cosmetic surgeries, cardiovascular treatments, infertility treatments, and dental procedures. ... Read More
-
Spain: Eye Care Products Market - Analysis, Size, Trends, Consumption, and Forecast
... market development in the medium term. The report provides a strategic analysis of the eye care products market in Spain and describes the main market participants, growth and demand drivers, challenges, and all other factors, ... Read More
-
Spain Ophthalmic Devices Market Outlook to 2033 - Corneal Implants, Glaucoma Surgery Devices, Intraocular Lens (IOL) and Others
... data on the Spain Ophthalmic Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories - Ophthalmic Viscoelastic Devices (OVD), Intraocular Lens (IOL), Glaucoma Surgery Devices, Ophthalmic Lasers ... Read More
-
2025 Europe Cancer Diagnostics Market in France, Germany, Italy, Spain, UK - 2024 Supplier Shares and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2024 supplier strategies and shares by country, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides ... Read More
-
Cannabis in Spain
... for medical cannabis is on the horizon, the lack of political will to regulate recreational cannabis results in a strong illegal market that accounts for an overwhelming share of total market value. Meanwhile, the fast-growing ... Read More
-
2024-2029 Europe Immunodiagnostic/Immunoassay Analyzers and Reagents - France, Germany, Italy, Spain, UK - 2024 Supplier Shares and Competitive Analysis, 2024-2029 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks
... and Special Chemistry Centralized and POC Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Challenges and Risks LeadingMarketResearch.com's new report is a five-country strategic analysis of major business opportunities emerging in ... Read More
-
AI in Drug Discovery Market in Spain
... growth patterns, and forecasts spanning the years 2021 to 2029. Gain insights into a comprehensive understanding of the industry landscape. Please note: the online download version of this report is for a global site license. Read More
-
Active Pharmaceutical Ingredients Market in Spain
... growth patterns, and forecasts spanning the years 2021 to 2029. Gain insights into a comprehensive understanding of the industry landscape. Please note: the online download version of this report is for a global site license. Read More
-
Europe Gut and Digestive Health Ingredients Market Research Report Information by Type (Prebiotics, Probiotics, Digestive Enzymes and Polyphenols), By Application (Dairy & Frozen, Desserts, Functional Foods, Functional Beverages, Dietary Supplements and Pharmaceuticals & Nutraceuticals), By End User (Commercial and Residential), By Distribution Channel (Direct and Indirect), and By Country (Germany, France, UK, Italy, Spain and Rest of Europe) Industry Forecast Till 2032
... End User (Commercial and Residential), By Distribution Channel (Direct and Indirect), and By Country (Germany, France, UK, Italy, Spain and Rest of Europe) Industry Forecast Till 2032 In 2023, the market size of gut and ... Read More
-
Generics in Spain
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
... (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry ... Read More
-
Connected Drug Delivery Devices Market by Type of Device (Connected / Smart Wearable Injectors, Connected / Smart Inhalers, Connected / Smart Pen Injectors, Connected / Smart Autoinjectors and Connected / Smart Needle-free Injection Systems), Mode of Connectivity (Bluetooth-enabled Devices, Near Field Communication-enabled Devices, Cellular-enabled Devices and Wide Area Network-enabled Devices), Route of Administration (Parenteral and Inhalational), Therapeutic Area (Metabolic Disorders, Respiratory Disorders, Autoimmune Disorders and Other Disorders), and Geographical Regions ((North America (US and Canada), Europe (UK, Germany, France, Italy, Spain and Rest of the Europe), Asia-Pacific (China, India, Japan and Rest of the Asia-Pacific), Middle East and North Africa (Egypt, Israel, Saudi Arabia, and Rest of the Middle East and North Africa), and Latin America and Rest of the World (Brazil, Argentina and Rest of the World)): Industry Trends and Global Forecasts, Till 2035
... of Connectivity (Bluetooth-enabled Devices, Near Field Communication-enabled Devices, Cellular-enabled Devices and Wide Area Network-enabled Devices), Route of Administration (Parenteral and Inhalational), Therapeutic Area (Metabolic Disorders, Respiratory Disorders, Autoimmune Disorders and Other Disorders), and Geographical Regions ... Read More
-
Spain Radiology Market Overview, 2029
... its pioneering contributions to medical imaging, with a market valued at approximately €1 billion and strong growth expected in the coming years. The market is segmented by modality, including MRI, CT scans, ultrasound, X-rays, nuclear ... Read More
-
2024-2029 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... LeadingMarketResearch.com is based on a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in the European market; reviews current and emerging ... Read More
-
2024-2029 Europe Molecular Genetic, Cancer, Forensic and Paternity Testing Market: France, Germany, Italy, Spain, UK - Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... five-country study from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic ... Read More
-
2024-2029 Europe Hepatitis Diagnostic Market for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT: France, Germany, Italy, Spain, UK - Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
2024-2029 Europe Drugs of Abuse Testing Market for 12 Assays - France, Germany, Italy, Spain, UK - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... for Suppliers This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . This new report from LeadingMarketResearch provides a comprehensive analysis of the European drug of abuse testing ... Read More
-
2024-2029 Europe Anemia Diagnostic Testing Market Assessment in France, Germany, Italy, Spain, UK - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities
... LeadingMarketResearch.com provides information and analysis not available from any other published source, including: Supplier Sales and Shares by Segment and Test Volume and Sales Segment Forecasts by Test Supplier Strategies and SWOT Analysis Instrumentation Pipeline ... Read More
-
Europe SGLT2 Inhibitors Market Share, Size, Trends, Industry Analysis Report: By Indication [Cardiovascular, Chronic Kidney Disease (CKD), Type 2 Diabetes, and Others], Drug, Distribution Channel, and Country (Germany, France, UK, Italy, Spain, Netherlands, Russia, and Rest of Europe) – Market Forecast, 2024–2032
... Rest of Europe) – Market Forecast, 2024–2032 The Europe SGLT2 inhibitors market size is expected to reach USD 7,629.79 million by 2032, according to a new study by Polaris Market Research. The report “Europe SGLT2 ... Read More
Research Assistance
